World Equity Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-443
Closed -$226K 328
2025
Q1
$226K Sell
443
-786
-64% -$316K 0.06% 276
2024
Q4
$453K Sell
1,229
-12
-1% -$5.02K 0.1% 205
2024
Q3
$645K Sell
1,241
-2,486
-67% -$1.33M 0.23% 103
2024
Q2
$2.02M Sell
3,727
-2,127
-36% -$1.12M 0.6% 40
2024
Q1
$3.04M Sell
5,854
-58
-1% -$28.8K 0.62% 36
2023
Q4
$2.79M Sell
5,912
-1,310
-18% -$606K 0.56% 38
2023
Q3
$3.14M Buy
7,222
+3,816
+112% +$1.73M 0.65% 28
2023
Q2
$1.51M Sell
3,406
-13,572
-80% -$6.26M 0.45% 52
2023
Q1
$833K Buy
16,978
+13,626
+407% +$6.48M 0.12% 190
2022
Q4
$1.72M Sell
3,352
-17
-0.5% -$8.63K 0.41% 69
2022
Q3
$1.53M Sell
3,369
-26
-0.8% -$12.4K 0.39% 69
2022
Q2
$1.64M Sell
3,395
-485
-13% -$240K 0.41% 65
2022
Q1
$1.91M Buy
+3,880
New +$1.77M 0.41% 63

Other funds holding ELV

World Equity Group's ELV Position: Q2 2025 in Review

World Equity Group sold out of Elevance Health (ELV) in Q2 2025, closing a stake of 443 shares — an estimated $226K sold.

World Equity Group first reported a position in ELV in Q1 2022 and held it in 13 quarters. The position peaked at $3.14M in Q3 2023. 1,589 funds tracked by Wall St. Rank hold ELV as of Q2 2025.

  • World Equity Group reported no remaining Elevance Health position as of Q2 2025 after selling out during the quarter.
  • World Equity Group sold 443 Elevance Health shares in Q2 2025, an estimated $226K.
  • World Equity Group first reported a position in Elevance Health in Q1 2022 and held it in 13 quarters.
  • World Equity Group's Elevance Health position peaked at $3.14M in Q3 2023.
  • 1,589 funds tracked by Wall St. Rank held Elevance Health as of Q2 2025.

Based on World Equity Group's 13F filing for Q2 2025, filed 15 Jul 2025.